Rock Springs Capital Management’s Xilio Therapeutics XLO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-3,003,259
| Closed | -$2.87M | – | 109 |
|
|
2024
Q4 | $2.87M | Hold |
3,003,259
| – | – | 0.11% | 88 |
|
|
2024
Q3 | $2.37M | Hold |
3,003,259
| – | – | 0.08% | 94 |
|
|
2024
Q2 | $2.85M | Buy |
3,003,259
+1,562,500
| +108% | +$1.48M | 0.09% | 96 |
|
|
2024
Q1 | $1.56M | Hold |
1,440,759
| – | – | 0.04% | 109 |
|
|
2023
Q4 | $792K | Hold |
1,440,759
| – | – | 0.02% | 100 |
|
|
2023
Q3 | $3.04M | Hold |
1,440,759
| – | – | 0.08% | 92 |
|
|
2023
Q2 | $3.77M | Hold |
1,440,759
| – | – | 0.09% | 94 |
|
|
2023
Q1 | $4.57M | Buy |
1,440,759
+77,881
| +6% | +$247K | 0.11% | 91 |
|
|
2022
Q4 | $3.67M | Hold |
1,362,878
| – | – | 0.09% | 95 |
|
|
2022
Q3 | $3.97M | Hold |
1,362,878
| – | – | 0.1% | 99 |
|
|
2022
Q2 | $3.98M | Buy |
1,362,878
+171,784
| +14% | +$502K | 0.12% | 101 |
|
|
2022
Q1 | $8.42M | Hold |
1,191,094
| – | – | 0.21% | 88 |
|
|
2021
Q4 | $19.1M | Buy |
+1,191,094
| New | +$19.1M | 0.44% | 66 |
|